| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H14Cl3N5O.ClH |
| Molecular Weight | 435.135 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC[C@@H]1CN2C(=N1)C3=C(NC(=N3)C4=CC(Cl)=CC(Cl)=C4Cl)N(C)C2=O
InChI
InChIKey=JUPMOTHIKGWECW-DDWIOCJRSA-N
InChI=1S/C16H14Cl3N5O.ClH/c1-3-8-6-24-15(20-8)12-14(23(2)16(24)25)22-13(21-12)9-4-7(17)5-10(18)11(9)19;/h4-5,8H,3,6H2,1-2H3,(H,21,22);1H/t8-;/m1./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H14Cl3N5O |
| Molecular Weight | 398.674 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.433 nM [Ki] | |||
| 1.7 µM [Ki] | |||
| 2.7 µM [Ki] | |||
| 0.441 nM [Ki] |
